Share-based Payment Arrangement, Expense in USD of Aquestive Therapeutics, Inc. from 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Aquestive Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2017 to Q3 2025.
  • Aquestive Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $2.78M, a 76.1% increase year-over-year.
  • Aquestive Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $8.65M, a 54% increase year-over-year.
  • Aquestive Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $7.1M, a 164% increase from 2023.
  • Aquestive Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2.69M, a 38.6% decline from 2022.
  • Aquestive Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.38M, a 35.8% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Aquestive Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $8.65M $2.78M +$1.2M +76.1% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 $7.45M $1.88M +$345K +22.4% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 $7.11M $1.59M +$7K +0.44% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025
Q4 2024 $7.1M $2.4M +$1.48M +160% 01 Oct 2024 31 Dec 2024 10-K 05 Mar 2025
Q3 2024 $5.62M $1.58M +$803K +104% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025
Q2 2024 $4.82M $1.54M +$891K +138% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025
Q1 2024 $3.93M $1.58M +$1.24M +359% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025
Q4 2023 $2.69M $923K +$211K +29.6% 01 Oct 2023 31 Dec 2023 10-K 05 Mar 2025
Q3 2023 $2.48M $774K +$239K +44.7% 01 Jul 2023 30 Sep 2023 10-Q 04 Nov 2024
Q2 2023 $2.24M $648K -$1.57M -70.8% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 $3.81M $344K -$569K -62.3% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024
Q4 2022 $4.38M $712K -$979K -57.9% 01 Oct 2022 31 Dec 2022 10-K 05 Mar 2024
Q3 2022 $5.36M $535K -$1.37M -71.8% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023
Q2 2022 $6.73M $2.22M +$500K +29.1% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023
Q1 2022 $6.23M $913K -$594K -39.4% 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023
Q4 2021 $6.82M $1.69M +$500K +42% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 $6.32M $1.9M +$135K +7.65% 01 Jul 2021 30 Sep 2021 10-Q 01 Nov 2022
Q2 2021 $6.18M $1.72M -$44K -2.49% 01 Apr 2021 30 Jun 2021 10-Q 02 Aug 2022
Q1 2021 $6.23M $1.51M -$353K -19% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022
Q4 2020 $6.58M $1.19M -$680K -36.3% 01 Oct 2020 31 Dec 2020 10-K 08 Mar 2022
Q3 2020 $7.26M $1.77M -$105K -5.62% 01 Jul 2020 30 Sep 2020 10-Q 02 Nov 2021
Q2 2020 $7.37M $1.77M -$45K -2.49% 01 Apr 2020 30 Jun 2020 10-Q 03 Aug 2021
Q1 2020 $7.41M $1.86M +$340K +22.4% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021
Q4 2019 $7.07M $1.87M 01 Oct 2019 31 Dec 2019 10-K 09 Mar 2021
Q3 2019 $1.87M +$634K +51.3% 01 Jul 2019 30 Sep 2019 10-Q 04 Nov 2020
Q2 2019 $1.81M -$25.5M -93.4% 01 Apr 2019 30 Jun 2019 10-Q 04 Aug 2020
Q1 2019 $1.52M 01 Jan 2019 31 Mar 2019 10-Q 05 May 2020
Q3 2018 $1.24M 01 Jul 2018 30 Sep 2018 10-Q 05 Nov 2019
Q2 2018 $27.3M 01 Apr 2018 30 Jun 2018 10-Q 06 Aug 2019

Aquestive Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $7.1M +$4.41M +164% 01 Jan 2024 31 Dec 2024 10-K 05 Mar 2025
2023 $2.69M -$1.69M -38.6% 01 Jan 2023 31 Dec 2023 10-K 05 Mar 2025
2022 $4.38M -$2.44M -35.8% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024
2021 $6.82M +$238K +3.62% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 $6.58M -$490K -6.93% 01 Jan 2020 31 Dec 2020 10-K 08 Mar 2022
2019 $7.07M -$22.9M -76.4% 01 Jan 2019 31 Dec 2019 10-K 09 Mar 2021
2018 $29.9M +$29.9M 01 Jan 2018 31 Dec 2018 10-K 11 Mar 2020
2017 $0 01 Jan 2017 31 Dec 2017 10-K 14 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.